FROM “THE” PATIENT TO PRE-EMPT: A JOURNEY FROM THE INDIVIDUAL TO GLOBAL HEALTH Peter von Dadelszen BMedSc, MBChB, DipObst, DPhil, FRANZCOG, FRCSC, FRCOG.

Slides:



Advertisements
Similar presentations
Maternal Safety Bundle for Severe Hypertension in Pregnancy
Advertisements

Jay Patel, MD CR FIRM C. Initial Evaluation What are the vitals? EKG Is this new or old? What has the rate of increase been? Is the patient mentating.
Hypertensive Crisis during Pregnancy Eric I. Rosenberg, MD, MSPH, FACP.
Hypertension in Pregnancy
The ACOG Task force on hypertension in pregnancy
HYPERTENSIVE DISORDERS OF PREGNANCY Dr. Dianne MP Graham, MD, CCFP Based on Guidelines From SOGC ALARM Course & WHO Guide on Managing Complications in.
Doug Simkiss Associate Professor of Child Health Warwick Medical School The principles of good neonatal care and why neonatal resuscitation is important.
BP>140/90 twice at resting 4 hours apart >0.5 g/L or >+ proteinuria in the absence of UTI (pyuria) Develops after 20th week and normalized within 3 months.
HYPERTENSIVE DISEASE IN PREGNANCY WITH ASSOCIATED NEONATAL OUTCOMES
Slides courtesy of Matt Hall Nottingham University Hospitals February 2011 Slides courtesy of Matt Hall Nottingham University Hospitals February 2011 Slides.
PRESENTATION ON SAFETY ISSUES RELEVANT TO HOME BIRTHS AND THE PROFESSIONALS WHO PROVIDE MATERNITY CARE SEPTEMBER 20, 2012 The Maryland Chapter of the American.
Choice of antihypertensive Peter von Dadelszen BMedSc, MBChB, DipObst, DPhil, FRANZCOG, FRCSC, FRCOG Associate Professor of Obstetrics & Gynaecology, UBC.
Obesity and Hypertension in Pregnancy: Does it matter afterwards? Prof Leonie Callaway.
MANAGEMENT OF THE OBESE PREGNANT PATIENT Max Brinsmead PhD FRANZCOG May 2010.
Pre- eclampsia ImpendingEclampsia It is a disease of pregnancy characterized by BP 140/ 90 or more. BP 140/ 90 or more. After 20 week gestational.
Sue Ann Smith, MD Neonatologist Doernbecher Neonatal Care Center
Pregnancy related Illnesses Preeclampsia  HTN, proteinuria & edema Eclampsia  Preeclampsia + Sz HELLP  Hemolysis, elevated LFT & Low plt count TTP.
Small Babies IUGR and SGA. Small-for-gestational-age A baby whose birth weight or estimated fetal weight is below a specified centile for its gestation.
HYPERTENSION DURING PREGNANCY Gestational HYPERTENSION
Eclampsia.
Introduction  Preterm birth is the leading cause of perinatal death.  Handicap in children and the vast majority of mortality and morbidity relates.
1-Gestetional Thrombocytopenia.
Pre-eclampsia, Eclampsia and HELLP syndrome Dr.Victor M De Leon Anzures Hospital O,horan UCIA Medicina Critica y Terapia Intensiva.
 To educate pregnant women on the importance of prenatal care and educate them on the complications that pertain to human pregnancy.  To be knowledgeable.
MANAGEMENT HTN IN PREGNANCY. DEFINITIONS The definition of gestational hypertension is somewhat controversial. Some clinicians therefore recommend close.
Underweight pregnant women in low risk populations: Does a low BMI (
Preventing Elective Deliveries Before 39 Weeks John R. Allbert Charlotte, NC.
Institute of Medicine Research Issues in the Assessment of Birth Settings: Assessment of Risk in Pregnancy Discussant M. Kathryn Menard, MD MPH Professor.
Quality Education for a Healthier Scotland Multidisciplinary Pre-eclampsia and Eclampsia Promoting multiprofessional education and development in Scottish.
Hypertensive Disorder
Postpartum Hypertension Lin-Fan Wang MD 5/4/09 PGY-1 OB/GYN Rotation Family and Social Medicine.
| Africa Regional Meeting on Interventions for Impact in Essential Maternal and Newborn Care, Addis Ababa, Feb 21, 2011 Timing of delivery and induction.
SEVERE ACUTE MATERNAL MORBIDITY/NEAR MISS MATERNAL MORBIDITY Sangeetagupta Seniorconsultant&HOD, Deptt of Obst.&Gynae,ESIPGIMSR,Basaidarapur.
Geneva, Switzerland, April 2012 PIERS on the Move – Phone Oximetry for Pre-Eclampsia Beth Payne Guy Dumont PhD Candidate Professor
HYPERTENSIVE DISORDER IN PREGNANCY AHMED ABDULWAHAB ASSISTANT PROFESSOR AND CONSULUTANT OB/GY.
PREECLAMPSIA / PREGNANCY INDUCED HYPERTENSION
Rafat Mosalli MD Abnormal Gestation. Objectives What is Normal gestation? What is Normal gestation? Newborn classification according to age and Weight.
Complication during pregnancy and its nursing management: - Pregnancy induces hypertension. Clinical Aspect of Maternal and Child Nursing NUR 363 Lecture.
Management of severe hypertension.  For women with persistent chronic hypertension with SBP >160 or DBP >105, start antihypertensive therapy  Maintain.
Homebirth? Max Brinsmead MB BS PhD December 2014.
Max Brinsmead MB BS PhD May Definition and Incidence  Prolonged pregnancy is defined as that proceeding beyond 42 weeks gestation  In the absence.
What do we know about preeclampsia?. Preeclampsia: a two stage disorder Stage 1: Reduced Placental perfusion abnormal implantation Stage 2: Maternal Syndrome.
THIRD TRIMESTER PROBLEMS Hypertension Small for dates Post-term pregnancy.
TIME OF DELIVERY IN HYPERTENSIVE DISORERS OF PREGNANCY Laleh Eslamian MD. Prof. of Obstet & Gynecol Perinatologist, Shariati hospital, TUMS.
PREECLAMPSIA & ECLAMPSIA
SARAH PIXTON AUGUST 2013 ORANGE BASE HOSPITAL Low Dose Aspirin In Pregnancy.
HYPERTENSIVE DISORDERS OF PREGNANCY. CLINICAL CLASSIFICATION OF HYPERTENSIVE DISORDERS OF PREGNANCY 1. Gestational hypertension (without proteinuria)
AHMED ABDULWAHAB ASSISTANT PROFESSOR AND CONSULUTANT OB/GY.
HYPERTENSIVEDISORDERS OF PREGNANCY. Pregnancy Induced Hypertension Hypertension/ or Proteinuria developing after 20 weeks of pregnancy, during labour.
Precepting the Prenatal Patient: A Curriculum for Non OB Family Medicine Physicians.
The hypertensive disorders of pregnancy (HDPs) – best practices Laura A. Magee, Professor of Maternal Medicine, SGUL Women Deliver 16 May 2016.
ORAL ANTIHYPERTENSIVE THERAPY FOR SEVERE HYPERTENSION IN PREGNANCY AND POSTPARTUM: A SYSTEMATIC REVIEW Tabassum FirozLaura Magee Karen MacDonellBeth Payne.
Dr. Hythem Al-Sum Consultant Obstetrics, ICU, MFM MNGHA KAMC-RD.
PREGNANCY INDUCED HYPERTENSION & ECLAMPSIA Wesley Edwards Wishaw General Hospital.
Alanna James. Hypertensive Disorders of Pregnancy (HDOP) Epidemiology Classification Risks of HDOP Pregnancy Induced Hypertension Pre eclampsia Eclampsia.
Hypertensive disorders in pregnancy Done by: Muhammad Samir Zuaiter Mini-OSCE simulation.
Critical care management of preeclampsia and eclampsia
Hypertensive Disorders of Pregnancy - Dr Thomas Carins
Clinical features Abnormal vasculogenesis and angiogenesis and releasing of anti-angiogenic factors results in Vasospasm Endothelial dysfunction Etiology.
Hypertension Disorders in Pregnancy
HTN Complications of Pregnancy
Pre-eclampsia Matthew Beaumont.
Chronic Hypertension Monitoring
James M. Roberts, M.D., Leslie Myatt, Ph.D.,et al.
Preeclampsia: an overview
Tabassum Firoz MD MSc FRCPC University of British Columbia
Maternal Mortality.
Preeclampsia: A renal perspective
Laura A. Magee, MD  Journal of Obstetrics and Gynaecology Canada  
Pre-eclampsia, Eclampsia and HELLP syndrome
Presentation transcript:

FROM “THE” PATIENT TO PRE-EMPT: A JOURNEY FROM THE INDIVIDUAL TO GLOBAL HEALTH Peter von Dadelszen BMedSc, MBChB, DipObst, DPhil, FRANZCOG, FRCSC, FRCOG Professor and Academic Head of Obstetrics & Gynaecology, SGUL Honorary Consultant in Obstetrics, SGFT 44 th APOG Meeting, 4 December 2015

Disclosures I have been a paid consultant to Alere International and have received unrestricted grants-in-aid from them to support some of the research presented I own shares in LGT Medical

Objectives Describe the important milestones in my journey as a clinician-scientist Primarily related to pre-eclampsia

Milestones Look at the big picture v1.1

Pre-eclampsia more than hypertension and proteinuria pre-eclampsia pulmonary oedema DIC/abruption hypertension stroke eclampsia proteinuria acute renal failure

Pre-eclampsia global burden Pre-eclampsia and the other HDP cause – IHME states 30,000 maternal deaths annually Kassebaum et al. Lancet 2014 – However, field data from Pakistan imply that 40% of 40,000 PPH deaths are attributable to pre-eclampsia upon review – Therefore, ≈46,000 maternal deaths annually At least one woman every 7 minutes – >500,000 perinatal deaths annually – ≈1500 deaths/d = 4 x A340s crashing daily However, no word for “pre-eclampsia” in Sindhi, Yoruba, Changana, Kannada … >99% of pre-eclampsia-related deaths occur in LMICs – Delays in triage, transport & treatment ≈50% of pre-eclampsia-related deaths occur in the home

Pre-eclampsia more than hypertension and proteinuria pre-eclampsia pulmonary oedema DIC/abruption hypertension stroke eclampsia proteinuria acute renal failure

Pre-eclampsia as PPH

Pre-eclampsia global burden Pre-eclampsia and the other HDP cause – IHME states 30,000 maternal deaths annually Kassebaum et al. Lancet 2014 – However, field data from Pakistan imply that 40% of 40,000 PPH deaths are attributable to pre-eclampsia upon review – Therefore, ≈46,000 maternal deaths annually At least one woman every 7 minutes – >500,000 perinatal deaths annually – ≈1500 deaths/d = 4 x A340s crashing daily However, no word for “pre-eclampsia” in Sindhi, Yoruba, Changana, Kannada … >99% of pre-eclampsia-related deaths occur in LMICs – Delays in triage, transport & treatment ≈50% of pre-eclampsia-related deaths occur in the home

Population-level incidence of HDP CLIP Trials Mozambique:Delivered women with hypertension: 70/964 (7.3%) Delivered women with proteinuric hypertension: 8/964 (0.8%)

GA at HDP recognition CLIP Trials

Mozambique: Completed pregnancies reporting severe hypertension: 20/964 (2.1%)

Milestones Look at the big picture v1.1 Look at the big picture v1.2

Data from CEMD,UK Maternal death from pre-eclampsia by diagnosis – UK; 1952 – 2008 Number of maternal deaths/triennium

Data from CEMD,UK Maternal death from pre-eclampsia by diagnosis – UK; 1952 – 2008 Number of maternal deaths/triennium AntihypertensivesMagnesium

Data from CEMD,UK Maternal death from pre-eclampsia by diagnosis – UK; 1952 – 2008 Number of maternal deaths/triennium AntihypertensivesMagnesium Surveillance, Timed delivery & Reproductive choice

Milestones Look at the big picture v1.1 Look at the big picture v1.2 Look at the big picture v1.3

cardiorespiratory hypertension ARDS pulmonary oedema cardiomyopathy / LV dysfunction intravascular volume constriction generalised oedema CNS eclampsia TIA / RIND / CVA PRES renal glomerular endotheliosis proteinuria ATN ARF hepatic periportal inflammation hepatic dysfunction / failure hepatic haematoma / rupture haematological microangiopathic haemolysis thrombocytopoenia DIC placental IUGR (± maternal syndrome) endothelial cell activation intervillous soup pre-eclampsia-specificshared with IUGR placental debris angiogenic imbalance innate immune activation oxidative stress eicosanoids cytokines uteroplacental mismatch decidual immune cell - EVT interactions (invasion & uteroplacental artery remodelling) inadequate placentation (early-onset pre-eclampsia) genetic factors familial risks SNPs epigenetics lowered threshold metabolic syndrome chronic infection / inflammation pre-existing hypertension chronic renal disease / DbM high altitude maternal syndrome normal placentation (late-onset pre-eclampsia) macrosomia multiple pregnancy ± lowered threshold immunological factors antigen exposure primigravidity ( ) / primipaternity ( ) donor gamete(s) ( ) duration of cohabitation ( ) barrier contraception ( ) / fellatio ( ) prior miscarriage ( ) smoking ( )

Milestones Look at the big picture v1.1 Look at the big picture v1.2 Look at the big picture v1.3 Your research is only as good as your controls

P L GF and IUGR vs constitutionally-small Preliminary data – Single site pilot study – Placental pathology to define placental IUGR Benton et al. AJOG 2011

P L GF and IUGR vs constutionally-small Constitutionally-small Placental IUGR Benton et al. submitted

STRIDER consortium of RCTs sildenafil 25mg tid NZ & Aus HRC (NZ) Netherlands (ZonMW) UK (MRC) ROI (HRB) Canada (CIHR)

cardiorespiratory hypertension ARDS pulmonary oedema cardiomyopathy / LV dysfunction intravascular volume constriction generalised oedema CNS eclampsia TIA / RIND / CVA PRES renal glomerular endotheliosis proteinuria ATN ARF hepatic periportal inflammation hepatic dysfunction / failure hepatic haematoma / rupture haematological microangiopathic haemolysis thrombocytopoenia DIC placental IUGR (± maternal syndrome) endothelial cell activation intervillous soup pre-eclampsia-specificshared with IUGR placental debris angiogenic imbalance innate immune activation oxidative stress eicosanoids cytokines uteroplacental mismatch decidual immune cell - EVT interactions (invasion & uteroplacental artery remodelling) inadequate placentation (early-onset pre-eclampsia) genetic factors familial risks SNPs epigenetics lowered threshold metabolic syndrome chronic infection / inflammation pre-existing hypertension chronic renal disease / DbM high altitude maternal syndrome normal placentation (late-onset pre-eclampsia) macrosomia multiple pregnancy ± lowered threshold immunological factors antigen exposure primigravidity ( ) / primipaternity ( ) donor gamete(s) ( ) duration of cohabitation ( ) barrier contraception ( ) / fellatio ( ) prior miscarriage ( ) smoking ( )

Milestones Look at the big picture v1.1 Look at the big picture v1.2 Look at the big picture v1.3 Your research is only as good as your controls Tell a story

cardiorespiratory hypertension ARDS pulmonary oedema cardiomyopathy / LV dysfunction intravascular volume constriction generalised oedema CNS eclampsia TIA / RIND / CVA PRES renal glomerular endotheliosis proteinuria ATN ARF hepatic periportal inflammation hepatic dysfunction / failure hepatic haematoma / rupture haematological microangiopathic haemolysis thrombocytopoenia DIC placental IUGR (± maternal syndrome) endothelial cell activation intervillous soup pre-eclampsia-specificshared with IUGR placental debris angiogenic imbalance innate immune activation oxidative stress eicosanoids cytokines uteroplacental mismatch decidual immune cell - EVT interactions (invasion & uteroplacental artery remodelling) inadequate placentation (early-onset pre-eclampsia) genetic factors familial risks SNPs epigenetics lowered threshold metabolic syndrome chronic infection / inflammation pre-existing hypertension chronic renal disease / DbM high altitude maternal syndrome normal placentation (late-onset pre-eclampsia) macrosomia multiple pregnancy ± lowered threshold immunological factors antigen exposure primigravidity ( ) / primipaternity ( ) donor gamete(s) ( ) duration of cohabitation ( ) barrier contraception ( ) / fellatio ( ) prior miscarriage ( ) smoking ( )

fullPIERS sites 2023 women von Dadelszen et al. Lancet 2011

Payne et al. PLoS Med 2014

home-based (± transfer to PHC) or PHC-based assessment & initial management App-guided CLIP package of care (≥1 trigger) 750mg methyldopa po (only if sBP ≥160; not repeated in PHC) 10g MgSO 4 im (if sBP ≥160, eclampsia, miniPIERS p ≥25%, pv bleeding + sBP≥140; not repeated in PHC) urgent transport (if sBP ≥160, eclampsia, coma, stroke, miniPIERS p ≥25%, pv bleeding, ++++ protein, no FM ≥12h) App-guided CLIP triggers to OVERCOMING initiate community interventions THE 3 DELAYS miniPIERS p ≥25% Triage/Transport/Treatment sBP ≥160Triage/Transport/Treatment eclampsiaTriage/Transport/Treatment pv bleeding (presumed abruption)Triage/Transport/Treatment ++++ proteinuriaTriage/Transport/Treatment absent fetal movements ≥12hTriage/Transport/Treatment community engagement & cHCP education urgent transport (<4h) (if: miniPIERS p ≥25%, sBP ≥160, stroke, coma, eclampsia, pv bleeding, ++++ protein, absent FM ≥12h) non-urgent transport (<24h) (if: miniPIERS p <25%, sBP mmHg, <++++ protein) facility capacity enhancement CME/CPD M&M reviews CEmOC facility for definitive care ongoing BP control ongoing MgSO 4 delivery – IOL vs C/S newborn care

community engagement & cHCP education urgent transport (<4h) (if: miniPIERS p ≥25%, sBP ≥160, stroke, coma, eclampsia, pv bleeding, ++++ protein, absent FM ≥12h) non-urgent transport (<24h) (if: miniPIERS p <25%, sBP mmHg, <++++ protein) facility capacity enhancement CME/CPD M&M reviews home-based (± transfer to PHC) or PHC-based assessment & initial management App-guided CLIP package of care (≥1 trigger) 750mg methyldopa po (only if sBP ≥160, dBP ≥110; not repeated in PHC) 10g MgSO 4 im (if sBP ≥160, dBP ≥110, eclampsia, miniPIERS p ≥25%, pv bleeding + sBP≥140; not repeated in PHC) urgent transport (if sBP ≥160, dBP ≥110, SI ≥1.7, eclampsia, coma, stroke, miniPIERS p ≥25%, pv bleeding, ++++ protein, no FM ≥12h) App-guided CLIP triggers to OVERCOMING initiate community interventions THE 3 DELAYS miniPIERS p ≥25% Triage/Transport/Treatment sBP ≥160Triage/Transport/Treatment dBP ≥110Triage/Transport/Treatment SI ≥1.7Triage/Transport/Treatment eclampsiaTriage/Transport/Treatment pv bleeding (presumed abruption)Triage/Transport/Treatment ++++ proteinuriaTriage/Transport/Treatment absent fetal movements ≥12hTriage/Transport/Treatment CEmOC facility for definitive care ongoing BP control ongoing MgSO 4 delivery – IOL vs C/S newborn care

Payne et al. JOGC 2015

additional 20% of women who will suffer adverse outcome identified increased from 65% to 85% additional 20% of women who will suffer adverse outcome identified increased from 65% to 85% Payne et al. JOGC 2015

community engagement & cHCP education urgent transport (<4h) (if: miniPIERS p ≥25%, sBP ≥160, stroke, coma, eclampsia, pv bleeding, ++++ protein, absent FM ≥12h) non-urgent transport (<24h) (if: miniPIERS p <25%, sBP mmHg, <++++ protein) facility capacity enhancement CME/CPD M&M reviews home-based (± transfer to PHC) or PHC-based assessment & initial management App-guided CLIP package of care (≥1 trigger) 750mg methyldopa po (if sBP ≥160; not repeated in PHC) 10g MgSO 4 im(if sBP ≥160, eclampsia, miniPIERS p ≥25%, pv bleeding + sBP≥140; not repeated in PHC) urgent transport (if sBP ≥160, SpO 2 <93%, eclampsia, coma, stroke, miniPIERS p ≥25%, pv bleeding, ++++ protein, no FM ≥12h) App-guided CLIP triggers to OVERCOMING initiate community interventions THE 3 DELAYS miniPIERS p ≥25% Triage/Transport/Treatment sBP ≥160Triage/Transport/Treatment SpO 2 <93% Triage/Transport/Treatment eclampsiaTriage/Transport/Treatment pv bleeding (presumed abruption)Triage/Transport/Treatment ++++ proteinuriaTriage/Transport/Treatment absent fetal movements ≥12hTriage/Transport/Treatment CEmOC facility for definitive care ongoing BP control ongoing MgSO 4 delivery – IOL vs C/S newborn care

cardiorespiratory hypertension ARDS pulmonary oedema cardiomyopathy / LV dysfunction intravascular volume constriction generalised oedema CNS eclampsia TIA / RIND / CVA PRES renal glomerular endotheliosis proteinuria ATN ARF hepatic periportal inflammation hepatic dysfunction / failure hepatic haematoma / rupture haematological microangiopathic haemolysis thrombocytopoenia DIC placental IUGR (± maternal syndrome) endothelial cell activation intervillous soup pre-eclampsia-specificshared with IUGR placental debris angiogenic imbalance innate immune activation oxidative stress eicosanoids cytokines uteroplacental mismatch decidual immune cell - EVT interactions (invasion & uteroplacental artery remodelling) inadequate placentation (early-onset pre-eclampsia) genetic factors familial risks SNPs epigenetics lowered threshold metabolic syndrome chronic infection / inflammation pre-existing hypertension chronic renal disease / DbM high altitude maternal syndrome normal placentation (late-onset pre-eclampsia) macrosomia multiple pregnancy ± lowered threshold immunological factors antigen exposure primigravidity ( ) / primipaternity ( ) donor gamete(s) ( ) duration of cohabitation ( ) barrier contraception ( ) / fellatio ( ) prior miscarriage ( ) smoking ( )

Milestones Look at the big picture v1.1 Look at the big picture v1.2 Look at the big picture v1.3 Your research is only as good as your controls Tell a story And finally …

Marry well!